Journal of Clinical Endocrinology & Metabolism, Vol 80, 846-851, Copyright © 1995 by Endocrine Society

ARTICLES

High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry

CL Vandewalle, A Falorni, S Svanholm, A Lernmark, DG Pipeleers and FK Gorus
Diabetes Research Centre, Vrije Universiteit Brussel, Belgium.

Patients with adult-onset Type 1 (insulin-dependent) diabetes mellitus (IDDM) are more difficult to identify than young patients, as their clinical onset is often less acute with a questionable state of insulin dependency. Classification may be facilitated by the detection of autoantibodies that are associated with IDDM. The prevalence of islet cell autoantibodies (ICA) and insulin autoantibodies (IAA) is, however, markedly lower in adult than in young patients. The present study assesses the usefulness of antibodies against glutamate decarboxylase (GAD), as a complementary marker. Sera from 312 recent-onset IDDM patients under age 40 and 163 age-matched controls were assayed for IAA, ICA, and antibodies against recombinant GAD65 (M(r) 65,000) or GAD67 (M(r) 67,000). IAA or ICA occurred in over 90% of patients diagnosed under age 20 but only in 65% of patients between age 20 and 40. Determination of GAD65-Ab did not increase the percent antibody positive patients under age 10, but did so at older ages: from 92-98% in the 10-19 years age group, and from 65-85% in the 20-39 years age group. The determination of GAD67-Ab did not add to the information provided by the GAD65-Ab assay. Our results indicate that, alone or in combination with ICA, the GAD65-Ab assay identified more patients with an IDDM marker in the age group 20-39 years than in the group under age 20.

This article has been cited by other articles:

				C. Tiberti, C. Giordano, M. Locatelli, E. Bosi, G. F. Bottazzo, R. Buzzetti, D. Cucinotta, A. Galluzzo, A. Falorni, and F. Dotta Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2 Diabetes, May 1, 2008; 57(5): 1276 - 1283. [Abstract] [Full Text] [PDF]

				M. GUPTA, J. GRAHAM, B. MCNEENY, M. ZARGHAMI, M. LANDIN-OLSSON, W. A HAGOPIAN, J. PALMER, A. LERNMARK, and C. B SANJEEVI MHC Class I Chain-Related Gene-A Is Associated with IA2 and IAA but Not GAD in Swedish Type 1 Diabetes Mellitus Ann. N.Y. Acad. Sci., October 1, 2006; 1079(1): 229 - 239. [Abstract] [Full Text] [PDF]

				A. De Bellis, M. Salerno, M. Conte, C. Coronella, G. Tirelli, M. Battaglia, V. Esposito, G. Ruocco, G. Bellastella, A. Bizzarro, et al. Antipituitary Antibodies Recognizing Growth Hormone (GH)-Producing Cells in Children with Idiopathic GH Deficiency and in Children with Idiopathic Short Stature J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2484 - 2489. [Abstract] [Full Text] [PDF]

				C. J. Padoa, J. P. Banga, A.-M. Madec, M. Ziegler, M. Schlosser, E. Ortqvist, I. Kockum, J. Palmer, O. Rolandsson, K. A. Binder, et al. Recombinant Fabs of Human Monoclonal Antibodies Specific to the Middle Epitope of GAD65 Inhibit Type 1 Diabetes-Specific GAD65Abs Diabetes, November 1, 2003; 52(11): 2689 - 2695. [Abstract] [Full Text] [PDF]

				K. Asao, C. Sarti, T. Forsen, V. Hyttinen, R. Nishimura, M. Matsushima, A. Reunanen, J. Tuomilehto, and N. Tajima Long-Term Mortality in Nationwide Cohorts of Childhood-Onset Type 1 Diabetes in Japan and Finland Diabetes Care, July 1, 2003; 26(7): 2037 - 2042. [Abstract] [Full Text] [PDF]

				I. Weets, V. Siraux, J.-C. Daubresse, I. H. De Leeuw, F. Fery, B. Keymeulen, G. Krzentowski, M. Letiexhe, C. Mathieu, F. Nobels, et al. Relation between Disease Phenotype and HLA-DQ Genotype in Diabetic Patients Diagnosed in Early Adulthood J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2597 - 2605. [Abstract] [Full Text] [PDF]

				A. FALORNI and F. CALCINARO Autoantibody Profile and Epitope Mapping in Latent Autoimmune Diabetes in Adults Ann. N.Y. Acad. Sci., April 1, 2002; 958(1): 99 - 106. [Abstract] [Full Text] [PDF]

				A. KANUNGO, K. C. SAMAL, and C. B. SANJEEVI Molecular Mechanisms Involved in the Etiopathogenesis of Malnutrition-Modulated Diabetes Mellitus Ann. N.Y. Acad. Sci., April 1, 2002; 958(1): 138 - 143. [Abstract] [Full Text] [PDF]

				A. L. Lethagen, U.-B. Ericsson, B. Hallengren, L. Groop, and T. Tuomi Glutamic Acid Decarboxylase Antibody Positivity Is Associated with an Impaired Insulin Response to Glucose and Arginine in Nondiabetic Patients with Autoimmune Thyroiditis J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1177 - 1183. [Abstract] [Full Text] [PDF]

				G. Gambelunghe, M. Ghaderi, C. Tortoioli, A. Falorni, F. Santeusanio, P. Brunetti, C. B. Sanjeevi, and A. Falorni Two Distinct MICA Gene Markers Discriminate Major Autoimmune Diabetes Types J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3754 - 3760. [Abstract] [Full Text] [PDF]

				V. Umpaichitra, W. Bastian, D. Taha, M. A. Banerji, T. W. AvRuskin, and S. Castells C-peptide and Glucagon Profiles in Minority Children with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1605 - 1609. [Abstract] [Full Text]

				B Wesche, E Jaeckel, C Trautwein, H Wedemeyer, A Falorni, H Frank, A von zur Muhlen, M-P Manns, and G Brabant Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C Gut, March 1, 2001; 48(3): 378 - 383. [Abstract] [Full Text] [PDF]

				C. Törn, M. Landin-Olsson, A. Lernmark, J. P. Palmer, H. J. Arnqvist, G. Blohmé, F. Lithner, B. Littorin, L. Nyström, B. Scherstén, et al. Prognostic Factors for the Course of {beta} Cell Function in Autoimmune Diabetes J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4619 - 4623. [Abstract] [Full Text]

				A. Falorni, G. Gambelunghe, F. Forini, G. Kassi, A. Cosentino, P. Candeloro, G. B. Bolli, P. Brunetti, and F. Calcinaro Autoantibody Recognition of COOH-Terminal Epitopes of GAD65 Marks the Risk for Insulin Requirement in Adult-Onset Diabetes Mellitus J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 309 - 316. [Abstract] [Full Text]

				M. R. Batstra, A. van Driel, J. S. Petersen, C. A. van Donselaar, M. J. van Tol, G. J. Bruining, D. E. Grobbee, T. Dyrberg, and H.-J. Aanstoot Glutamic Acid Decarboxylase Antibodies in Screening for Autoimmune Diabetes: Influence of Comorbidity, Age, and Sex on Specificity and Threshold Values Clin. Chem., December 1, 1999; 45(12): 2269 - 2272. [Full Text] [PDF]

				A. Pugliese, E. Kawasaki, M. Zeller, L. Yu, S. Babu, M. Solimena, C. T. Moraes, M. Pietropaolo, R. P. Friday, M. Trucco, et al. Sequence Analysis of the Diabetes-Protective Human Leukocyte Antigen-DQB10602 Allele in Unaffected, Islet Cell Antibody-Positive First Degree Relatives and in Rare Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1722 - 1728. [Abstract] [Full Text]

				C. S. Hampe, E. Örtqvist, O. Rolandsson, M. Landin-Olsson, C. Törn, A. Ågren, B. Persson, D. B. Schranz, and A. Lernmark Species-Specific Autoantibodies in Type 1 Diabetes J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 643 - 648. [Abstract] [Full Text]

				H. Tanaka, M. S. Perez, M. Powell, J. F. Sanders, J. Sawicka, S. Chen, L. Prentice, T. Asawa, C. Betterle, M. Volpato, et al. Steroid 21-Hydroxylase Autoantibodies: Measurements with a New Immunoprecipitation Assay J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1440 - 1446. [Abstract] [Full Text] [PDF]

				H. Borg, P. Fernlund, and G. Sundkvist Measurement of antibodies against glutamic acid decarboxylase 65 (GADA): two new 125I assays compared with [35S]GAD 65-ligand binding assay Clin. Chem., May 1, 1997; 43(5): 779 - 785. [Abstract] [Full Text] [PDF]